Monitor for activation of the FSS contract in Q3 2026 and any subsequent revenue disclosures in quarterly filings. The agreement expands addressable market but lacks near-term financial impact; watch for procurement orders from government facilities.
Price Chart
Executive Summary
Microbot Medical entered into a vendor agreement with Lovell Government Services to sell its LIBERTY Endovascular Robotic System at more than 2,000 U.S. government facilities, including VA, DoD, and Indian Health Service sites. The LIBERTY System will be added to Lovell's Federal Supply Schedule contract with activation expected in Q3 2026. No financial terms or revenue projections were disclosed.
Key Facts
- Agreement with Lovell Government Services, a Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor.
- Access to more than 2,000 government facilities including VA, DoD, and Indian Health Service.
- LIBERTY System to be added to Lovell's Federal Supply Schedule (FSS) contract, activation expected Q3 2026.
- Lovell serves 170 medical centers and numerous outpatient clinics, averaging over 200 peripheral endovascular cases annually per site.
- Products also accessible via GSA Advantage, ECAT, and DAPA procurement platforms.
Financial Impact
No financial terms or revenue projections disclosed; agreement is a commercial distribution channel expansion.
Risk Factors
- Activation of FSS contract may be delayed beyond Q3 2026.
- No guaranteed minimum purchase commitments; revenue dependent on adoption.
- Competition from other endovascular robotic systems in government procurement.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-028824 |
| Exhibit: ex99-1.htm | 0001493152-26-028824 |
| Document: 0001493152-26-028824-index-headers.html | 0001493152-26-028824 |
| Document: 0001493152-26-028824-index.html | 0001493152-26-028824 |
| Document: 0001493152-26-028824.txt | 0001493152-26-028824 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.9799 | awaiting T+1 | — | $0.9826 (+0.28%) |
Oct 20, 2026 6d ago | 8-K | $0.9475 $0.9401 | ▼ −0.78% | ▼ −1.31% | $0.9826 (+3.70%) |
Oct 6, 2026 20d ago | 8-K | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9826 (−8.17%) |
Oct 6, 2026 20d ago | Press Release | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9826 (−8.17%) |
Sep 28, 2026 28d ago | 8-K | $1.25 $1.25 | ▼ −0.40% | ▼ −0.22% | $0.9826 (−21.39%) |
Aug 11, 2026 10w ago | 8-K | $1.68 $1.74 | ▲ +3.27% | ▲ +3.02% | $0.9826 (−41.51%) |
Jul 21, 2026 13w ago | 8-K | $1.80 $1.77 | ▼ −1.67% | ▼ −1.55% | $0.9826 (−45.41%) |
Jul 7, 2026 15w ago | 8-K | $1.90 $1.87 | ▼ −1.58% | ▼ −1.27% | $0.9826 (−48.28%) |
Jun 30, 2026 16w ago | 8-K | $1.95 $1.91 | ▼ −2.05% | ▼ −1.92% | $0.9826 (−49.61%) |
Jun 16, 2026 18w ago | 8-K | $1.82 $1.88 | ▲ +3.30% | ▲ +4.55% | $0.9826 (−46.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers